💥 Dragon Pharma

GHK-Cu Basic

✔️ Substance: Tripeptide-1
✔️ Price For: Vial 50 mg
✔️ Brand: Dragon Pharma

Out of stock

Dragon Pharma GHK-Cu Basic 50 mg

IDENTITYCompoundGHK-Cu Basic
SubstanceCopper Tripeptide-1 (GHK-Cu)
Strength50 mg
FormLyophilized Peptide Vial
ClassCopper-Binding Peptide

PEPTIDE PROFILEPeptide TypeTripeptide Complex
SequenceGly-His-Lys + Copper Ion
Primary FunctionTissue Repair Signaling
Biological RoleExtracellular Matrix Support
CategoryResearch Peptide

PHARMACOLOGYTargetCopper-Dependent Pathways
ActivityCellular Signaling Modulation
CollagenSupportive Regulation
InflammationModulatory Effects
AdministrationSubcutaneous Injection

STORAGE & RECONSTITUTIONBrandDragon Pharma
Package50 mg Multi-dose Vial
Storage2–8°C Recommended
ProtectionLight & Moisture Protection
ReconstitutionSterile Diluent Required

DOSING INFORMATIONResearch Range1–2 mg/day
Weekly Amount7–14 mg/week
AdministrationSubcutaneous Injection
FrequencyDaily or Split Schedule
Duration4–12 weeks

USAGE PROFILETypical UsagePeptide Research Protocols
Injection TimeMorning or Evening
Cycle Length4–12 Weeks
ObservationGradual Biological Response
StabilityRequires Cold Storage

ADMINISTRATIONRouteSubcutaneous (SC)
Injection SiteCommon SC Areas
FrequencyDaily Administration
TimingConsistent Schedule
PreparationAseptic Technique

BODYBUILDING USAGERecoveryTissue Support
Skin QualityCollagen Pathway Support
TrainingRecovery-Focused Use
CombinationRecovery Peptide Protocols
Muscle EffectIndirect Support

RECOVERY PROFILEPCTNot Required
Hormonal SuppressionNot Typical
DiscontinuationGradual Protocol End
MonitoringGeneral Health Markers
RecoverySupportive Peptide Profile

COMPATIBILITYRecovery StackRecovery Peptides
Training SupportNutrition & Sleep Optimization
Research UseCombination Studies
HormonesNo Direct Androgen Activity
SupportGeneral Regeneration Research

MECHANISM OF ACTIONBindingCopper Ion Complex Formation
PathwayCellular Repair Signaling
CollagenExtracellular Matrix Support
AngiogenesisResearch-Associated Regulation
SkinDermal Remodeling Support

PHARMACOKINETICSAbsorptionPeptide Dependent
DistributionTissue Interaction
MetabolismPeptide Degradation Pathways
ClearanceBiological Peptide Breakdown
DurationShort Biological Activity

SAFETY PROFILEHormonal EffectNo Direct Testosterone Suppression
Liver ToxicityNot Characteristic
Injection RiskAseptic Handling Required
Copper BalanceMonitor Excess Exposure
Long-Term DataLimited Research Availability

CONTRAINDICATIONSCopper DisordersAvoid Medical Contraindications
PregnancyNot Recommended
AllergyPeptide Sensitivity Assessment
Medical ConditionsProfessional Evaluation
InjectionProper Technique Required

CHEMICAL PROFILECompoundCopper Tripeptide-1
SequenceGly-His-Lys
Molecular TypeCopper-Binding Peptide
CategoryBioactive Peptide
FormulaC14H24N6O4

OVERVIEW

Dragon Pharma GHK-Cu Basic 50 mg contains Copper Tripeptide-1 (GHK-Cu), a naturally occurring copper-binding peptide involved in cellular signaling and extracellular matrix regulation. GHK-Cu has been investigated for its relationship with collagen production, tissue remodeling, wound healing processes, and skin biology through copper-dependent mechanisms.

BENEFITS

Supports collagen-related pathways
Research interest in tissue repair
Supports extracellular matrix activity
May assist skin quality research
Non-androgenic peptide profile
Recovery-focused application
Copper-dependent biological activity

POTENTIAL RISKS

Injection site irritation
Limited long-term human data
Possible copper imbalance concerns
Unknown individual response
Storage sensitivity
Product handling risks
Medical contraindication considerations

PERFORMANCE PROFILE

Recovery Support

80%

Collagen Support

85%

Tissue Research

75%

Direct Muscle Gain

20%

Hormonal Impact

10%

WHAT IS DRAGON PHARMA?

Dragon Pharma is a pharmaceutical-style brand name commonly associated with research and performance-related compounds. Products marketed under this name are presented with specific compound identification, dosage formats, and laboratory-style packaging.

WHY CHOOSE DRAGON PHARMA

Dragon Pharma products are selected by users interested in clearly identified compounds, standardized presentation, and pharmaceutical-style information. GHK-Cu Basic provides a defined 50 mg vial format designed for peptide research applications where accurate compound identification and storage conditions are important factors.

Responsible evaluation should always include product authenticity, scientific evidence, proper handling, and awareness that research peptides may have limited approved clinical applications depending on jurisdiction.

CONCLUSION

Dragon Pharma GHK-Cu Basic 50 mg contains Copper Tripeptide-1 (GHK-Cu), a bioactive peptide complex studied for its interaction with copper-dependent biological pathways, extracellular matrix regulation, and tissue remodeling processes.

Unlike anabolic steroids or growth hormone compounds, GHK-Cu does not directly stimulate androgen receptors or provide classical anabolic effects. Its primary interest within sports and bodybuilding communities is related to recovery-focused research, connective tissue support, skin biology, and regenerative pathways.

The peptide requires appropriate storage conditions, careful preparation, and responsible administration practices. Current scientific understanding supports continued investigation, while users should consider the limited availability of large-scale clinical data for performance-related applications.

DISCLAIMER

This content is provided exclusively for educational and informational purposes. It does not constitute medical advice, treatment recommendations, or endorsement of non-approved peptide use. Research compounds should only be evaluated according to applicable regulations and professional medical guidance.